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KAJIAN PERBANDINGAN INDEKS SEL DARAH MERAH DALAM 
KALANGAN INDIVIDU PENGHIDAP OVALOSITOSIS ASIA TENGGARA 
(SAO), ANEMIA AKIBAT KEKURANGAN ZAT BESI (IDA) DAN SAO 
DENGAN IDA 
ABSTRAK 
Pengenalan: Ovalositosis Asia Tenggara (SAO) dan anemia akibat kekurangan zat besi 
(IDA) merupakan penyakit yang biasa berlaku di Malaysia. Kedua-duanya mempunyai 
corak parameter sel darah merah (RBC) tertentu namun mempunyai ciri-ciri morfologi 
yang saling bertindih antara satu sama lain. Apabila pesakit SAO mempunyai IDA, ia 
memberikan satu cabaran untuk membezakan keadaan ini. Oleh itu, kajian ini bertujuan 
untuk mengkaji parameter RBC dalam tiga kumpulan individu dengan SAO sahaja, 
IDA sahaja dan SAO dengan IDA dan mengenal pasti parameter yang berpotensi dalam 
mendiskriminasi ketiga-tiga keadaan ini. 
 
Metodologi: Kajian rentas keratan retrospektif ini dijalankan dalam kalangan 79 subjek 
dari Institut Perubatan dan Pergigian Termaju (IPPT), USM (30 kes dengan SAO sahaja 
dan IDA sahaja dan 19 kes SAO dengan IDA). Data diperoleh dari sistem maklumat 
makmal (LIS) di Makmal Diagnostik Lanjutan dari Januari 2010 hingga Mei 2019. 
Analisis univariable (Ujian ANOVA atau Kruskal-Wallis) digunakan untuk 
membandingkan parameter sel darah merah antara ketiga-tiga kumpulan ini, iaitu 
parameter RBC, Hb, MCV, MCH, MCHC dan RDW. Kepentingan statistik telah 




Keputusan: SAO dengan IDA menunjukkan purata RBC, Hb, MCV, MCH, MCHC 
dan RDW sebanyak 3.5 x 10
6
/μL, 9.2 g/dL, 74.6 fL, 25.7 pg, 33.7 g/dL dan 46.0 fL. 
Tiga parameter sel darah merah iaitu Hb, MCV dan MCH dalam kumpulan SAO 
dengan IDA menunjukkan nilai yang lebih rendah berbanding dengan kumpulan SAO 
sahaja (P<0.001). Walau bagaimanapun, parameter RBC, MCHC dan RDW 
menunjukkan nilai yang tidak ketara antara kedua-dua kumpulan (P>0.05). 
 
Kesimpulan: Tiga parameter sel darah merah iaitu Hb, MCV dan MCH, mempunyai  
potensi untuk mendiskriminasi antara pesakit yang mempunyai SAO dengan IDA dan 
SAO sahaja. Oleh itu, bagi pusat-pusat hematologi yang tidak mempunyai kemudahan 
untuk menganalisis sel darah merah menggunakan teknologi mesin terkini, ketiga-tiga 
parameter asas ini berpotensi menjadi panduan kepada pemilihan ujian profil besi atau 
analisis Hb bagi pengesahan diagnosis IDA atau talasemia (di mana secara klinikal 
ditunjukkan) bagi mengoptimumkan pengurusan pesakit. Walau bagaimanapun, ini 
merupakan kajian awal dan saiz sampel yang lebih besar diperlukan dalam penyelidikan 
masa depan. 
 








A COMPARISON STUDY OF RED BLOOD CELL INDICES IN 
SOUTHEAST ASIAN  OVALOCYTOSIS (SAO), IRON DEFICIENCY 
ANAEMIA (IDA) AND SAO WITH CONCOMITANT IDA 
ABSTRACT 
Introduction: Southeast Asian ovalocytosis (SAO) and iron deficiency anaemia (IDA) 
are common in Malaysia. Both have specific red blood cells (RBC) parameters pattern 
but overlapping morphological features. When SAO patients having concomitant IDA, 
it is quite challenging to differentiate them. Thus, the study aims to study RBC 
parameters in three groups of individuals with SAO alone, IDA alone and SAO with 
concomitant IDA and identifying potential parameters in discriminating them.  
 
Methodology: A retrospective cross-sectional study was conducted among 79 subjects 
from Institut Perubatan dan Pergigian (IPPT), USM (30 cases with SAO alone and IDA 
alone and 19 cases SAO with IDA). The data were obtained from the laboratory 
information system (LIS) of Advanced Diagnostic Laboratory from January 2010 to 
May 2019. Univariable analysis (One-way ANOVA or Kruskal-Wallis test) was used to 
compare the red blood cell parameters between the three groups, which include RBC, 
Hb, MCV, MCH, MCHC and RDW. Statistical significance was set at a P-value of  
<0.05. 
 
Results: SAO with concomitant IDA showed mean of RBC, Hb, MCV, MCH, MCHC 
and RDW of 3.5 x 10
6
/μL, 9.2 g/dL, 74.6 fL, 25.7 pg, 33.7 g/dL and 46.0 fL, 
respectively. It was found that the Hb, MCV and MCH of SAO with concomitant IDA 
group were lower compared to the SAO alone group with significance P-value 
xvii 
 
(P<0.001). However, the RBC count, MCHC and RDW parameters were not significant 
between both groups (P>0.05). 
 
Conclusion: Three RBC parameters, namely Hb, MCV and MCH, were shown to be 
potential parameters to discriminate between patients SAO with concomitant IDA and 
SAO alone. Therefore, in a centre where advance haematology analyser is not available, 
these three basic parameters may be potentially used to guide ordering of iron profile or 
Hb analysis for confirmatory diagnosis of IDA or thalassaemia trait (where clinically 
indicated) to optimise patients management. However, this is a preliminary study, and 
larger sample size is needed in future research. 
 



























CHAPTER 1  
 
INTRODUCTION 
1.1 Study Background 
 
Hereditary Elliptocytosis (HE) characterised by the presence of elongated or 
oval shape of erythrocytes that is due to red blood cell membrane defects. It is rare in 
the United States and Europe but high in malaria endemic-region, such as African and 
Southeast Asia (Naeim et al., 2013). In a full blood picture, the most prominent finding 
is the oval shape and elongated red blood cells. HE is occurred due to defects in various 
membrane proteins resulting in weakness of the skeleton membrane of erythrocytes. 
Most of the HE cases affecting the spectrin dimer-to-dimer lateral bonds or the spectrin-
ankyrin-protein 4.1 junction complex. It is classified into three subtypes according to 
morphology, which are Common Elliptocytosis, Spherocytic Elliptocytosis and 





























Common HE, as the name itself, it is the most common form of elliptocytosis. 
About 5 to 10% cases present with haemolytic anaemia with mostly elliptical shape 
(ellipse shape), some ovalocytes, and rod-shaped (Figure 1.2) (Da Costa et al., 2013; 
Fathima and Sitalakshmi, 2013). Mutation in α or β chains are the leading causes of 
typical HE, and it has wide distribution, most commonly affected persons from African 
origin, but it is also present in other populations as well (Conboy et al., 1991). 
Spherocytic elliptocytosis is a rare disease, an elliptocytosis and spherocytosis 
phenotypic hybrid with the presence of variable numbers of elliptocytes and some 
spherocytes. Hereditary elliptocytosis and hereditary spherocytosis are the most 
prevalent red cell membrane diseases in the area of North America, and Northern 
European countries with an incidence of about 0.05% (one out of 2000) affected cases. 
Because of underdiagnosis of asymptomatic forms, it is also probable to be even higher. 
 
Southeast Asian ovalocytosis is characterised by oval-shaped red cells, tend to 
appear as stomatocytes and knizocytes (Figure 1.3). The distribution of SAO is more 
restricted than common elliptocytosis, which appears to be restricted to Southeast Asia 
and individual Western Pacific islands (Nurse et al., 1992). It has a high prevalence in 
the area where malaria is endemic such as Melanesia, Indonesia and Southern Thailand 
and thus, it is giving advantage to the individual with SAO phenotypes with the 
protection against both Plasmodium falciparum and Plasmodium vivax (Mohandas and 
An, 2012; Rosanas-Urgell et al., 2012). In this study, we are going to focus on SAO 
















Figure 1.2 Hereditary elliptocytosis with ellipse shape (red arrows) and more ovalocytic 














Figure 1.3 Morphologic consequence of SAO with the presence of ovalocytosis along 
with stomatocytes and knizocytes (arrow) on peripheral blood smears. Figure adapted 






1.2 The Rationale of the Study 
 
If there is more than 25% stated cells in the full blood picture (FBP), diagnosis 
ovalocytosis can be made. The incidence is one case in 2000 to 4000 individuals 
worldwide, but the exact true incidence is not known since the majority of the patients 
are asymptomatic (Gallagher, 2004). In Malaysia, the prevalence of SAO in the Malay 
population in Kelantan was reported as high as 4% (Yusoff et al., 2003).  
 
Iron deficiency is one of the significant nutritional deficiencies in industrialised 
and developing nations, including Malaysia. The World Health Organization (WHO) 
estimated that around 50% of the two billion people suffering from anaemia are due to 
an iron deficiency (World Health Organization, 2007). For iron deficiency anaemia 
(IDA), the prevalence reported ranged from 7.4% in the town area to 34% in a rural area 
(Al-Mekhlafi et al., 2013; Nadarajan and Eow, 2002). 
 
In FBP of IDA, pencil-shaped cells, cigar cells and elliptocytes were commonly 
found in IDA patients. However, through these FBP findings, it is difficult to tell 
whether patients with SAO having concomitant IDA or not as the morphology in SAO 
can be confusing, and some are overlapping. The status of iron deficiency is usually be 
confirmed by doing serum ferritin. Bone marrow aspirate becomes the gold standard to 
assess the iron storage; however, this technique not routinely done due to the invasive 
technique. The concentration of serum ferritin is used as an iron store index as the 
quantity of ferritin relative to iron concentration in the body: about 8 mg of storage iron 
is equal to 1 ng/mL of ferritin. 
 
Although most of the hospitals are using the latest full blood count machine such 
as Sysmex XE5000, where iron status can be predicted from the reading of particular 
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parameter, namely retic haemoglobin (RET-He), however, due to budget constraint, 
some district hospitals do not have these privileges and still using the old, outdated 
machine. This old machine has only provided the primary parameter such as MCV, 
MCH and MCHC. Therefore, a haematologist who works in these district hospitals may 
encounter difficulty differentiating SAO with concomitant IDA. It is because the 
morphology of SAO red blood cells is not the same as in a typical IDA RBC 
morphology. In SAO, the RBC usually are macroovalocytes with stomatocyte and 
knizocytes while in pure IDA, the RBC morphology consists of pencil shape, cigar 
shape and hypochromic microcytic RBC. In an event where these two diseases co-exist 
together, we do not know how it may affect the primary RBC parameters. 
 
To date, no study has been conducted to study these haematological parameters 
in SAO patients with concomitant IDA and thus to differentiate it from SAO with no 
iron deficiency cases. From the literature review, many studies are only focusing on 
differentiating IDA with thalassaemia trait. A study from Liao et al. (2014) shows that 
the measurement of mean cell volume (MCV) and mean sphered cell volume (MSCV) 
able to discriminate between an individual with hereditary spherocytosis and 
thalassaemia rapidly. In 2016, related research by January F Matos in Sao Paulo 
developed a new parameter, known as Matos & Carvalho Index, with a cut-off point of 
23.85 to differentiate between IDA and thalassaemia. IDA is categorised as <23.85, 
while values >23.85 classify the patient as a carrier of thalassaemia (Matos et al., 2016). 
Another study by Bose and Maimoon (2018) assess the accuracy of Mentzer index in 
IDA and thalassaemia differentiation. The result shows that Mentzer index of equal to 
or more than 13 (≥13) indicating iron deficiency anaemia and less than 13 indicating 





 Therefore, in this study, we are focusing on RBC indices between patients of 
IDA and those with SAO co-inheritance. It is hoped that from this study, we can get 
haematological parameter values that can rapidly discriminate SAO patients having 
concomitant with IDA with SAO patients without IDA. A haematologist may rapidly 
screen and identify SAO patients with possible iron deficiency based on the RBC, Hb, 
MCV, MCH, MCHC and RDW parameter index and thus suggest for iron deficiency 
workup to the clinicians. 
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1.3 Objectives of the Study 
1.3.1 General Objectives 
To study red blood cell indices, namely RBC, Hb, MCV, MCH, MCHC and RDW 
values in three groups of individuals with SAO alone, IDA alone and SAO with 
concomitant IDA. 
1.3.2 Specific Objectives 
1) To determine the latest prevalence and demographic characteristics of SAO disease 
patients in Institut Perubatan & Pergigian Termaju (IPPT), USM Bertam. 
 
2) To compare red blood cell indices, namely RBC, Hb, MCV, MCH, MCHC and RDW 




















CHAPTER 2  
 
LITERATURE REVIEW 
2.1 Southeast Asian Ovalocytosis (SAO) 
2.1.1 Red Blood Cell Membrane Structure 
Mature red blood cells (RBC) have unique morphology that makes it easy to 
recognise. RBC have a biconcave-disc shape that is essential for normal function and 
with 120 days of survival in the peripheral circulation. It has a diameter of 
approximately 6 to 8 millimetre (mm), 2 mm thickness and an average volume of 
approximately 90 femtolitres (fL) with a surface area of about 136 mm (Figure 2.1). It 
has lacks of nucleus or mitochondria, and about 30% of its content is made up of 
haemoglobin. The plasma membrane is a lipid bilayer embedded in proteins and linked 
to the underlying protein cytoskeleton, and it is the key to maintaining the shape 
(Kohaine et al., 2016).  
 
The biconcave shape of RBC depends on vertical and horizontal interactions 
between integral membrane proteins and cytoskeletal protein. Ankyrin and protein 4.1 
are the two major transmembrane protein complexes, whereas the two major 
cytoskeleton protein is α-spectrin and β-spectrin. The transmembrane protein 
complexes, which are ankyrin complex and protein 4.2 complex form the vertical 
interaction (Figure 2.2). Ankyrin complex links transmembrane protein and band 3 to 
the cytoskeleton while protein 4.1 complex links transmembrane proteins, glycophorin 
C to the cytoskeleton, and adducin links transmembrane proteins, band 3 and glucose 
transport (Kohaine et al., 2016). α-spectrin and β-spectrin formed flexible rod-like 
heterodimers that form tetramers together with other spectrin heterodimers (Kohaine et 
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al., 2016; Tse and Lux, 1999). The spectrin heterodimers also form a spectrin-actin-
protein 4.1 junctional complex with accessory proteins such as tropomyosin, 
tropomodulin and adducin, resulting in the horizontal interaction stability. 
 
Any defects in the interaction between components of the red cell can affect the 
structure and function of the membrane, which can be further divided into those affects 
the vertical interactions and horizontal interactions. Changes in vertical and horizontal 
interactions result in changes in the density of the spectrum network, which invariably 
creates modifications in cell morphology, membrane instabilities and RBC 
deformability for many RBC hereditary disorders (Diez-Silva et al., 2010). Hereditary 
elliptocytosis or inherited pyropoikilocytosis have been related to deficiencies in 
horizontal interaction, while deficiencies in vertical interactions can lead to hereditary 
































Figure 2.1 Morphology of healthy red blood cells (arrow) with the presence of 




















Figure 2.2 The schematic diagram of the red blood cell membrane, specifying the 












2.1.2 Aetiology of SAO 
Southeast Asian ovalocytosis (SAO) is a unique hereditary type of elliptocytosis 
commonly found in Southeast Asian countries, including Malaysia, Indonesia, and the 
Philippines (Tse and Lux, 1999; Yusoff et al., 2003). It is an autosomal-dominant red 
blood cell abnormality that results from the removal of 27 base pairs on chromosome 17 
in exon 11 of the band 3 protein gene (Jarolim et al., 1991). Band 3 is the main 
transmembrane protein, also known as anion exchanger 1. This transmembrane protein 
is essential for maintaining both intracellular environments, by passive anion transport 
and its shape through attachment via ankyrin to spectrin in the cytoskeleton protein 
(Jay, 1996).  
 
The molecular genetic defect in SAO is the result of the deletion in SLC4A1 of 
27 base pairs, the gene that encodes for band 3 membrane proteins. This gene defect 
results in the removal of nine amino acids (codon 400 to 408) in the edge of the band 3 
cytoplasmic and membrane domains that are closely related to the Lys 56-to-Glu 
substitution (Jarolim et al., 1991; Liu et al., 1995). In the RBC membrane, band 3 is the 
most abundant protein which consists of two domains; N-terminal 41-kD cytoplasmic 
domain of band 3 (cdb3) and C-terminal 56-kD membrane domain. Several research 
revealed the biochemical, biophysical and ultrastructural implications of this mutation, 
including a marked reduction in lateral membrane mobility of band 3, enhanced 
extensional membrane rigidity, enhanced association of band 3 with membrane 
skeleton, enhanced tendency to form oligomers and linear membrane aggregates, and 
reduced anion transport activity (Liu et al., 1995; Mohandas et al., 1992; Schofield et 






Besides, the inheritance of these mutations provides a selective advantage over 
the survival of the severe complications of malaria diseases endemic to Southeast Asia 
(Jeng and Vichinsky, 2004). These ovalocytes were indeed resistant to invasion by 
several strains of the plasmodium malaria, including Plasmodium falciparum and 
Plasmodium knowlesi following research in vitro (Jarolim et al., 1991). A study by 
Mohandas et al. (1984) revealed that the marked rise in ovalocyte membrane rigidity 
resulted in resistance to parasite invasion. The changes in the RBC membrane and anion 
transport activity induced by SAO could affect the development of malaria parasites in 
several ways, including altering the parasite ability to grow within the erythrocyte, 
inhibiting the growth of parasites within the RBC of SAO and impairing the parasite's 






2.1.3 Clinical Description of SAO 
SAO is also called Melanesian elliptocytosis or elliptocytosis stomatocyte. Like 
the name itself, it is due to the existence of rounded elliptocytes or ovalocytes and 
distinctive longitudinal slit stomatocytes on the peripheral blood smear of individuals 
with SAO (Figure 2.3) (Golafshan et al., 2014). Deletion of codons 400 to 408 in the 
SLC4A1 gene encoding the band 3 erythrocyte membrane protein responsible for an 
abnormal erythrocyte stiffness and oval shape on the blood smear. Most people with 
SAO heterozygosity are asymptomatic with no clinically detectable haemolysis while 
homozygous deletion of SAO is considered to be fatal in the embryonic state and is not 
feasible without extensive antenatal care (Amato and Booth, 1977; Moulin et al., 2017). 
SAO can occur at any age. SAO usually asymptomatic in adults; however, SAO may be 




















Figure 2.3 Morphology of red blood cells in Southeast Asian ovalocytosis with one to 











2.2 Prevalence  
2.2.1 Prevalence of SAO 
As mentioned earlier, SAO is an autosomal dominant form of inherited 
elliptocytosis prevalent in Southeast Asian communities, including those of Papua New 
Guinea with elevated coastal and lowland incidence (Amato and Booth, 1977; 
O'Donnell et al., 1998). The incidence ranges from 5 to 25% in Indonesia, Philippines, 
Melanesia and Southern Thailand, where it mostly affected the regions of malaria-
endemic (Fathima and Sitalakshmi, 2013). A study by Mgone et al. (1996) showed the 
incidence of erythrocyte band 3 deletion range from zero in both the lowland coastal 
region of Wosera, East Sepik Province and the Goroka (highland areas), Eastern 
Highlands Province to 35% on the west shore of Madang Province. 
 
  The incidence mostly associated well with altitude where malaria 
transmission is high at the highest on the shoreline, intermediate in the lowlands and 
lowest in the non-malarious highlands. In Indonesia, Kimura et al. (2002) recorded an 
incident of SAO around 12.6%. The incidence of SAO is about 4% in the Malaysian 
population (Yusoff et al., 2003). Although there is no knowledge of the accurate 
distribution in distinct ethnic groups in Malaysia, study by Eng (1965) showed that the 
prevalence of inherited ovalocytosis was 12.3% in the Senoi tribe populations of 
Malaysia. SAO was found in 18 of the 22 patients with distal renal tubular acidosis 
(dRTA) (81.8%), but only two of the 50 healthy volunteers (4%) in Malays in Kelantan, 
Malaysia. This research by Yusoff et al. (2003) showed a significantly high incidence of 
SAO in those with dRTA, indicating a dysfunctional role of band 3 protein/AE1 in the 




2.2.2 Prevalence of IDA 
In developing countries, the prevalence of anaemia is three to four times greater 
than in industrialised countries. The World Health Organization (WHO) indicated in 
2002 that IDA becomes one of the ten most significant contributing factors to the global 
disease burden that raises morbidity and mortality in children and pregnant ladies. Of 
the two billion anaemic individuals, about 50% are due to iron deficiencies (World 
Health Organization, 2007). 
 
In Malaysia, for those aged 15 years and above, the overall prevalence of 
anaemia in 2015 was 24.6% (Institute for Public Health, 2015). It is estimated that 30% 
of the population of the world is influenced by IDA and mostly by those living in 
developing countries (Vehapoglu et al., 2014). The group of peoples who are at risk to 
develop IDA are young children, adolescent females and pregnant women due to their 
high iron demands (ACC/SCN, 2000; Al-Mekhlafi et al., 2013). Approximately 50% of 
East Asian school-aged children and 60% of children under the age of five were 





2.3 SAO with Other Complication 
2.3.1 SAO with distal Renal Tubular Acidosis (dRTA) 
In the same patient, familial distal renal tubular acidosis (dRTA) and SAO may 
coexist. It is due to the mutations of the AE1 gene, which codes the bicarbonate or 
chloride exchanger for band 3. Band 3 protein is not only expressed in the membrane of 
red blood cells, but also distal renal tubules (Wrong et al., 2002). In Malays of 
Kelantan, Malaysia, the incidence of SAO was examined in dRTA, which is about 
81.8% in 22 dRTA patients and 4% in 50 healthy individuals (Yusoff et al., 2003). 
Failure to produce a normal minimum urine pH (pH<5.5) is the characteristic of dRTA 
patients even in the presence of severe systemic acidosis (Wrong et al., 2002; Yusoff et 
al., 2003). The result from the impaired secretion of hydrogen ions from the distal 
nephron, leading to metabolic acidosis, frequently with nephrocalcinosis, hypokalaemia 



















2.3.2 SAO with Thalassaemia trait 
Thalassaemia is a genetic disease triggered by haemoglobin chains synthesis 
defects. These syndromes are among the world's most common genetic disorders, 
carrying thalassaemic mutations with approximately 1.7% of the world's population 
(Urrechaga et al., 2011). β-thalassaemia is one of the types of thalassaemia that caused 
by deficient or absent synthesis of β-globin chains, leading to excess α-chains. Synthesis 
of β-globin is controlled by one gene on each chromosome 11. The production of the β-
globin chain can range from near normal to completely absent, depends on the varying 
degrees of excess α-globin to β-globin chain production.  
 
If one gene defect, it can lead to β-thalassaemia trait (minor). Individuals are 
known to have β-thalassaemia major when the synthesis from both genes is severely 
reduced or absent. While, the person has β-thalassaemia intermedia when the synthesis 
of β-chains is less severely reduced (Herbert and James, 2009). Among those three, β-
thalassaemia trait (β-TT) is the most common type of haemoglobinopathy transmitted 
by heredity (Vehapoglu et al., 2014). Individuals with β-TT are generally 
asymptomatic, and individuals are unaware of their carrier status unless diagnosed by 
screening. It is estimated that around 50% of the world’s β-TT population are in 
Southeast Asia, the Mediterranean area, the Middle East, Southwest Europe and Central 
Africa (Urrechaga et al., 2011). Thalassaemia is a public health issue in Malaysia, with 
approximately 4.5% of Malays, and Chinese are carriers of β-thalassaemia (George, 
2001). 
 
SAO and β-TT are relatively common genetic disorders in Malaysia. Despite the 
relatively high incidence of these two diseases in Malaysia, SAO and β-TT co-
inheritance is rarely stated because the RBC indices are ignored and peripheral blood 
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smear tests are not routine. (Raman et al., 2015). When SAO and β-thalassaemia 
separately inherited as heterozygous, conditions are usually clinically mild (Chen et al., 
2017). The study from Fucharoen et al. (2007) showed that the peripheral blood film 


































2.3.3 SAO with Iron Deficiency Anaemia (IDA) 
Anaemia is a condition where there are inadequate red blood cells to meet 
human physiological needs and is usually confirmed by looking at the haemoglobin 
level. It can be caused by many factors, the most common being deficiency of vital 
components for haemoglobin synthesis (iron, vitamin B12 and folic acid), blood loss, 
reproductive age-female with repeated pregnancies, worm infestation, haemolysis and 
conditions of bone marrow causing suppression of red cell synthesis. The most common 
contributing factor to anaemia is iron deficiency anaemia (IDA) due to the absence of 
adequate iron to synthesise haemoglobin. 
 
SAO and IDA seem to be the most common haematological disorder in 
Southeast Asia, including in Malaysia. The prevalence of SAO among Malaysian 
population is 4%  (Yusoff et al., 2003) and the prevalence of IDA ranged from 7.4% in 
town area to 34% in a rural area (Al-Mekhlafi et al., 2013; Nadarajan and Eow, 2002). 
Therefore, the chances of both disorders occur together may be high and could have 
some effects on RBC parameters. However, the data and research posed in patients with 
the association of these two disorders are still limited. Therefore, in this study, we are 




2.4 Diagnostic Methods 
2.4.1 Peripheral Blood Smear 
Initially, SAO is most often suspected based on a routine peripheral blood smear 
(PBS). PBS is the first line of investigation as abnormalities observed in some red cell 
morphology may indicate that patients can be suspected of having such particular 
haematological disorder. It is often the first indication of this form of red cell disorder, 
including hereditary spherocytosis (HS), hereditary elliptocytosis (HE) and inherited 
pyropoikilocytosis (HPP) disorder (Delaunay, 2007). The criteria for diagnosing SAO 
in older children and adults are the presence of RBC with two or more linear or 
irregularly shaped pale regions and 20% of ovalocytes present in PBS (O'Donnell et al., 
1998). It is crucial to detect SAO heterozygosity by careful examination of RBC 
morphology in PBS in countries where DNA analysis is not available (Laosombat et al., 
2005). 
 
PBS is pathognomonic in a patient with pure SAO, characterising with macro-
ovalocytes with stomatocytes more than 25%. Usually, these ovalocytes have double Y- 
or V-shaped central pallors without polychromasia (Raman et al., 2015). Characteristic 
of alterations in red blood cell morphology of SAO can be identified by the presence of 
ovalocytes (red cells with a ratio of width: length >1:1 and <2:1), stomatocytes (central 
region of pallor with single slit-like) and knizocytes (red cell with two or more pale 
region with narrow separated) (Amato and Booth, 1977). Cook et al. (2009) noted that 
both P. falciparum and P. vivax parasite levels in vivo were considerably lower in 
individuals with ovalocyte compared to those with normal red cells, while parasite 
invasion of rigid ovalocyte membranes was lowered in vitro. Unlike SAO with marked 
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ovalocytic red cells, both IDA and β-TT commonly presented with microcytosis and 
hypochromia (Jameel et al., 2017). It is difficult to distinguish between the 
morphological results in both IDA and β-TT. Thalassaemia generally characterises a 
mild to moderate microcytic anaemia, sometimes presumptively diagnosed as IDA. 
Therefore, differentiating between these two anaemias is clinically relevant because 
both have a completely different cause, therapy and prognosis (Eldibany et al., 1999).  
 
Microcytosis usually occurs due to quantitative lack of synthesis of haemoglobin 
resulting from defects in either haem or globin chains production comprising the 
molecule of haemoglobin. Patient diagnosis of IDA by PBS often reveals 
anisopoikilocytosis with the presence of codocytes (target cells), elliptocytes (cigar-
shaped) and bizarre RBC. Pencil cells are also commonly seen, and it is more numerous 
in IDA compare than in β-thalassaemia (Harrington et al., 2008). A study by Urrechaga 
et al. (2011) reported that RBC tends to be more hypochromic and less microcytic in 































Figure 2.4  Patient with iron deficiency anaemia with microcytic and hypochromic red 
blood cell, (Wright stain, original magnification x1000). Figure adapted from Meredith 
and Rosenthal (1999).   
 
 
 
